あすか製薬ホールディングスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/12/30 | 1,298 | 1,311 | 1,289 | 1,297 | +4 | +0.3% | 49,000 |
| 2022/12/29 | 1,264 | 1,299 | 1,264 | 1,293 | +22 | +1.7% | 50,700 |
| 2022/12/28 | 1,265 | 1,293 | 1,260 | 1,271 | -5 | -0.4% | 74,900 |
| 2022/12/27 | 1,275 | 1,282 | 1,259 | 1,276 | +1 | +0.1% | 31,300 |
| 2022/12/26 | 1,290 | 1,296 | 1,272 | 1,275 | +3 | +0.2% | 26,100 |
| 2022/12/23 | 1,270 | 1,284 | 1,263 | 1,272 | -3 | -0.2% | 50,100 |
| 2022/12/22 | 1,260 | 1,277 | 1,257 | 1,275 | +27 | +2.2% | 40,900 |
| 2022/12/21 | 1,241 | 1,260 | 1,234 | 1,248 | +8 | +0.6% | 47,200 |
| 2022/12/20 | 1,273 | 1,280 | 1,231 | 1,240 | -27 | -2.1% | 72,700 |
| 2022/12/19 | 1,263 | 1,278 | 1,260 | 1,267 | +4 | +0.3% | 49,800 |
| 2022/12/16 | 1,258 | 1,278 | 1,258 | 1,263 | +4 | +0.3% | 73,200 |
| 2022/12/15 | 1,258 | 1,270 | 1,251 | 1,259 | -8 | -0.6% | 41,500 |
| 2022/12/14 | 1,258 | 1,288 | 1,255 | 1,267 | +24 | +1.9% | 129,600 |
| 2022/12/13 | 1,239 | 1,254 | 1,233 | 1,243 | +18 | +1.5% | 43,700 |
| 2022/12/12 | 1,220 | 1,233 | 1,208 | 1,225 | +9 | +0.7% | 35,500 |
| 2022/12/09 | 1,200 | 1,233 | 1,200 | 1,216 | +8 | +0.7% | 28,200 |
| 2022/12/08 | 1,215 | 1,219 | 1,203 | 1,208 | +3 | +0.2% | 38,700 |
| 2022/12/07 | 1,212 | 1,219 | 1,203 | 1,205 | -11 | -0.9% | 44,000 |
| 2022/12/06 | 1,189 | 1,226 | 1,189 | 1,216 | +16 | +1.3% | 73,300 |
| 2022/12/05 | 1,221 | 1,221 | 1,187 | 1,200 | -26 | -2.1% | 76,500 |
| 2022/12/02 | 1,277 | 1,277 | 1,226 | 1,226 | -61 | -4.7% | 86,400 |
| 2022/12/01 | 1,276 | 1,288 | 1,271 | 1,287 | +8 | +0.6% | 56,900 |
| 2022/11/30 | 1,284 | 1,290 | 1,269 | 1,279 | +12 | +0.9% | 58,200 |
| 2022/11/29 | 1,253 | 1,275 | 1,250 | 1,267 | +8 | +0.6% | 51,100 |
| 2022/11/28 | 1,237 | 1,267 | 1,236 | 1,259 | +13 | +1% | 52,800 |
| 2022/11/25 | 1,240 | 1,252 | 1,240 | 1,246 | -1 | -0.1% | 48,200 |
| 2022/11/24 | 1,240 | 1,259 | 1,231 | 1,247 | +17 | +1.4% | 70,800 |
| 2022/11/22 | 1,205 | 1,234 | 1,203 | 1,230 | +27 | +2.2% | 85,400 |
| 2022/11/21 | 1,175 | 1,208 | 1,174 | 1,203 | +38 | +3.3% | 89,300 |
| 2022/11/18 | 1,155 | 1,168 | 1,151 | 1,165 | +16 | +1.4% | 27,800 |
| 2022/11/17 | 1,141 | 1,153 | 1,139 | 1,149 | +4 | +0.3% | 20,600 |
| 2022/11/16 | 1,137 | 1,154 | 1,133 | 1,145 | +8 | +0.7% | 22,200 |
| 2022/11/15 | 1,114 | 1,148 | 1,114 | 1,137 | +23 | +2.1% | 32,300 |
| 2022/11/14 | 1,123 | 1,124 | 1,114 | 1,114 | -7 | -0.6% | 34,900 |
| 2022/11/11 | 1,144 | 1,144 | 1,112 | 1,121 | -2 | -0.2% | 58,900 |
| 2022/11/10 | 1,145 | 1,145 | 1,121 | 1,123 | -27 | -2.3% | 59,300 |
| 2022/11/09 | 1,188 | 1,188 | 1,146 | 1,150 | -33 | -2.8% | 52,900 |
| 2022/11/08 | 1,159 | 1,187 | 1,155 | 1,183 | +36 | +3.1% | 104,200 |
| 2022/11/07 | 1,150 | 1,163 | 1,143 | 1,147 | +9 | +0.8% | 29,900 |
| 2022/11/04 | 1,150 | 1,156 | 1,133 | 1,138 | -14 | -1.2% | 54,500 |
| 2022/11/02 | 1,157 | 1,162 | 1,148 | 1,152 | -10 | -0.9% | 22,000 |
| 2022/11/01 | 1,175 | 1,183 | 1,156 | 1,162 | -10 | -0.9% | 34,200 |
| 2022/10/31 | 1,150 | 1,177 | 1,149 | 1,172 | +37 | +3.3% | 44,700 |
| 2022/10/28 | 1,130 | 1,152 | 1,125 | 1,135 | -6 | -0.5% | 124,500 |
| 2022/10/27 | 1,149 | 1,151 | 1,138 | 1,141 | -13 | -1.1% | 24,700 |
| 2022/10/26 | 1,139 | 1,154 | 1,134 | 1,154 | +18 | +1.6% | 20,100 |
| 2022/10/25 | 1,141 | 1,153 | 1,130 | 1,136 | -3 | -0.3% | 35,700 |
| 2022/10/24 | 1,145 | 1,151 | 1,139 | 1,139 | +1 | +0.1% | 24,700 |
| 2022/10/21 | 1,137 | 1,147 | 1,135 | 1,138 | -8 | -0.7% | 27,700 |
| 2022/10/20 | 1,147 | 1,151 | 1,141 | 1,146 | -21 | -1.8% | 21,800 |
601～
650
件表示中 / 1029件
類似銘柄と比較する
現在ご覧いただいている「あすかＨＤ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| あすかＨＤ | 232,400円 | +16.9% | +33.2% | 2.37% | 12.68倍 | 1.01倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。２１年春にあすか製薬が持株会社化 |
| ネクセラファーマ | 90,300円 | +20.3% | - | 0.00% | 160.11倍 | 1.20倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| ＪＣＲファーマ | 55,200円 | +14.3% | - | 3.62% | 22.42倍 | 1.43倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
| タウンズ | 58,000円 | +4.6% | +6.1% | 4.83% | 9.88倍 | 3.66倍 |
|
院内で行う迅速抗原検査の体外診断薬専業大手。新型コロナ、インフルなど呼吸器感染症首位 |
| ヘリオス | 51,500円 | +150.0% | - | 0.00% | - | 25.33倍 |
|
ｉＰＳ細胞、体性幹細胞を活用する再生医薬品バイオベンチャー。住友ファーマと共同開発も |
市場注目の銘柄
チャート関連のコラム
